• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲磺酸伊马替尼在治疗剂量下对白血病小鼠模型的卵泡发生或精子发生没有影响。

Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.

机构信息

Department of Haematology, Imperial College and Hammersmith Hospital, London, UK.

出版信息

Leuk Res. 2012 Mar;36(3):271-4. doi: 10.1016/j.leukres.2011.09.025. Epub 2011 Oct 20.

DOI:10.1016/j.leukres.2011.09.025
PMID:22018447
Abstract

Imatinib should be avoided in women planning to become pregnant or during pregnancy, due to a higher risk of congenital malformations. However, it is not known whether imatinib affects future potential for fertility. Here we analysed ovaries and testes from adult mice receiving imatinib, focusing on testicular and ovarian functions. Seven male and 7 female mice were orally treated with 150 mg/kg body weight/day imatinib for two months. No effects on folliculogenesis or spermatogenesis could be observed postmortem by histological examinations, suggesting that, at least in two mouse models of imatinib treatment this tyrosine kinase inhibitor does not reduce fertility.

摘要

由于存在先天畸形的更高风险,伊马替尼应避免在计划怀孕或怀孕期间的女性中使用。然而,尚不清楚伊马替尼是否会影响未来的生育能力。在这里,我们分析了接受伊马替尼治疗的成年小鼠的卵巢和睾丸,重点研究了睾丸和卵巢功能。7 只雄性和 7 只雌性小鼠经口给予 150mg/kg 体重/天的伊马替尼治疗两个月。通过组织学检查在死后未观察到对卵泡发生或精子发生的影响,这表明,至少在两种伊马替尼治疗的小鼠模型中,这种酪氨酸激酶抑制剂不会降低生育能力。

相似文献

1
Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.甲磺酸伊马替尼在治疗剂量下对白血病小鼠模型的卵泡发生或精子发生没有影响。
Leuk Res. 2012 Mar;36(3):271-4. doi: 10.1016/j.leukres.2011.09.025. Epub 2011 Oct 20.
2
Imatinib does not impair gonadal function.
Leuk Res. 2012 Mar;36(3):262-3. doi: 10.1016/j.leukres.2011.11.003. Epub 2011 Nov 30.
3
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.甲磺酸伊马替尼可减少细胞外基质的产生,并预防实验性皮肤纤维化的发展。
Arthritis Rheum. 2007 Jan;56(1):311-22. doi: 10.1002/art.22314.
4
Hematological and molecular response evaluation of CML patients on imatinib.伊马替尼治疗的慢性粒细胞白血病患者的血液学和分子反应评估
J Assoc Physicians India. 2007 Feb;55:109-13.
5
Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat.甲磺酸伊马替尼对酪氨酸激酶血小板衍生生长因子受体(PDGFR)和C-Kit的抑制作用会干扰大鼠出生后的睾丸发育。
Int J Androl. 2007 Aug;30(4):366-76; discussion 376. doi: 10.1111/j.1365-2605.2007.00755.x.
6
Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).采用放疗与伊马替尼(格列卫)联合治疗的人胶质母细胞瘤和癌异种移植肿瘤。
Strahlenther Onkol. 2006 Jul;182(7):400-7. doi: 10.1007/s00066-006-1445-8.
7
CML: imatinib mesylate (Glivec) or something else?慢性粒细胞白血病:甲磺酸伊马替尼(格列卫)还是其他药物?
Nepal Med Coll J. 2007 Dec;9(4):292.
8
[Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].BCR/ABL酪氨酸激酶特异性抑制剂甲磺酸伊马替尼对慢性髓性白血病急变期的疗效
Ai Zheng. 2004 Dec;23(12):1696-9.
9
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.慢性髓性白血病完全细胞遗传学缓解后与伊马替尼相关的骨髓再生障碍
J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.
10
The metabolic consequences of imatinib mesylate: Changes on glucose, lypidic and bone metabolism.甲磺酸伊马替尼的代谢后果:对葡萄糖、脂质和骨代谢的影响
Leuk Res. 2009 Jul;33(7):871-5. doi: 10.1016/j.leukres.2009.01.040.

引用本文的文献

1
Effect of Imatinib Mesylate on the Ovarian Reserves of Female Patients with Chronic Myeloid Leukaemia.甲磺酸伊马替尼对慢性髓性白血病女性患者卵巢储备功能的影响
Indian J Hematol Blood Transfus. 2025 Apr;41(2):327-332. doi: 10.1007/s12288-024-01846-3. Epub 2024 Aug 27.
2
Management of CML and Pregnancy in Low-and Middle-income Countries.低收入和中等收入国家慢性粒细胞白血病与妊娠的管理
Indian J Hematol Blood Transfus. 2025 Jan;41(1):1-9. doi: 10.1007/s12288-024-01930-8. Epub 2024 Nov 19.
3
Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies.
靶向抗癌治疗后的潜在卵巢毒性和不孕风险。
Reprod Fertil. 2022 Jul 11;3(3):R147-R162. doi: 10.1530/RAF-22-0020. eCollection 2022 Jul 1.
4
Impact of imatinib administration on the mouse ovarian follicle count and levels of intra-ovarian proteins related to follicular quality.伊马替尼给药对小鼠卵巢卵泡数量及与卵泡质量相关的卵巢内蛋白质水平的影响。
Clin Exp Reprod Med. 2022 Jun;49(2):93-100. doi: 10.5653/cerm.2022.05218. Epub 2022 May 30.
5
Can Some Anticancer Treatments Preserve the Ovarian Reserve?某些抗癌治疗方法能否保留卵巢储备?
Oncologist. 2021 Jun;26(6):492-503. doi: 10.1002/onco.13675. Epub 2021 Jan 29.
6
Impact of imatinib or dasatinib coadministration on in vitro preantral follicle development and oocyte acquisition in cyclophosphamide-treated mice.伊马替尼或达沙替尼联合给药对环磷酰胺处理小鼠体外窦前卵泡发育和卵母细胞获取的影响。
Clin Exp Reprod Med. 2020 Dec;47(4):269-276. doi: 10.5653/cerm.2020.03755. Epub 2020 Nov 24.
7
Selective lysine-specific demethylase 1 inhibitor, NCL1, could cause testicular toxicity via the regulation of apoptosis.选择性赖氨酸特异性去甲基酶 1 抑制剂 NCL1 可能通过调节细胞凋亡引起睾丸毒性。
Andrology. 2020 Nov;8(6):1895-1906. doi: 10.1111/andr.12846. Epub 2020 Jul 15.
8
Lapatinib‑induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro.拉帕替尼诱导的卵巢功能抑制在体内和体外均可被 STAT3 通路拮抗。
Oncol Rep. 2020 Sep;44(3):1127-1135. doi: 10.3892/or.2020.7660. Epub 2020 Jun 24.
9
Long-term imatinib diminishes ovarian reserve and impacts embryo quality.长期伊马替尼会降低卵巢储备并影响胚胎质量。
J Assist Reprod Genet. 2020 Jun;37(6):1459-1466. doi: 10.1007/s10815-020-01778-7. Epub 2020 May 6.
10
Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.慢性髓性白血病的妊娠结局:单中心经验
J Glob Oncol. 2019 Sep;5:1-11. doi: 10.1200/JGO.18.00211.